These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34952177)

  • 1. Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.
    Fuertes M; Selas A; Trejo A; Knudsen BR; Palacios F; Alonso C
    Bioorg Med Chem Lett; 2022 Feb; 57():128517. PubMed ID: 34952177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.
    Alonso C; Fuertes M; Martín-Encinas E; Selas A; Rubiales G; Tesauro C; Knudssen BK; Palacios F
    Eur J Med Chem; 2018 Apr; 149():225-237. PubMed ID: 29501943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.
    Martín-Encinas E; Rubiales G; Knudssen BR; Palacios F; Alonso C
    Eur J Med Chem; 2019 Sep; 178():752-766. PubMed ID: 31229877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity.
    Alonso C; Fuertes M; González M; Rubiales G; Tesauro C; Knudsen BR; Palacios F
    Eur J Med Chem; 2016 Jun; 115():179-90. PubMed ID: 27017547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.
    Peterson KE; Cinelli MA; Morrell AE; Mehta A; Dexheimer TS; Agama K; Antony S; Pommier Y; Cushman M
    J Med Chem; 2011 Jul; 54(14):4937-53. PubMed ID: 21710981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.
    Martín-Encinas E; Selas A; Tesauro C; Rubiales G; Knudsen BR; Palacios F; Alonso C
    Eur J Med Chem; 2020 Jun; 195():112292. PubMed ID: 32279049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives.
    Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP
    J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.
    Martín-Encinas E; Rubiales G; Knudsen BR; Palacios F; Alonso C
    Bioorg Med Chem; 2021 Jun; 40():116177. PubMed ID: 33962152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.
    Tseng CH; Tzeng CC; Yang CL; Lu PJ; Chen HL; Li HY; Chuang YC; Yang CN; Chen YL
    J Med Chem; 2010 Aug; 53(16):6164-79. PubMed ID: 20662543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.
    Beck DE; Abdelmalak M; Lv W; Reddy PV; Tender GS; O'Neill E; Agama K; Marchand C; Pommier Y; Cushman M
    J Med Chem; 2015 May; 58(9):3997-4015. PubMed ID: 25909279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of substituted indeno[1,2-b]quinoline-6-carboxamides, [1]benzothieno[3,2-b]quinoline-4-carboxamides and 10H-quindoline-4-carboxamides: evaluation of structure-activity relationships for cytotoxicity.
    Chen J; Deady LW; Desneves J; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
    Bioorg Med Chem; 2000 Oct; 8(10):2461-6. PubMed ID: 11058041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5H-indeno[1,2-b]pyridine derivatives: Antiproliferative and antimetastatic activities against two human prostate cancer cell lines.
    Charris KE; Rodrigues JR; Ramírez H; Fernandez-Moreira E; Ángel JE; Charris JE
    Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100092. PubMed ID: 33928662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Flourophenyl-substituted 5H-indeno[1,2-b]pyridinols with enhanced topoisomerase IIα inhibitory activity: Synthesis, biological evaluation, and structure-activity relationships.
    Kunwar S; Hwang SY; Katila P; Seo M; Man Kadayat T; Kwon Y; Lee ES
    Bioorg Chem; 2021 Nov; 116():105349. PubMed ID: 34536927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
    Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ring-substituted 11-oxo-11H-indeno[1,2-b]quinoline-6-carboxamides with similar patterns of cytotoxicity to the dual topo I/II inhibitor DACA.
    Deady LW; Desneves J; Kaye AJ; Thompson M; Finlay GJ; Baguley BC; Denny WA
    Bioorg Med Chem; 1999 Dec; 7(12):2801-9. PubMed ID: 10658584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships.
    Kiselev E; Agama K; Pommier Y; Cushman M
    J Med Chem; 2012 Feb; 55(4):1682-97. PubMed ID: 22329436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 1,5-naphthyridines as topoisomerase I inhibitors. A new family of antiproliferative agents.
    Alonso C; Fuertes M; González M; Rodríguez-Gascón A; Rubiales G; Palacios F
    Curr Top Med Chem; 2014; 14(23):2722-8. PubMed ID: 25515747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
    Kadayat TM; Song C; Shin S; Magar TB; Bist G; Shrestha A; Thapa P; Na Y; Kwon Y; Lee ES
    Bioorg Med Chem; 2015 Jul; 23(13):3499-512. PubMed ID: 26022080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity.
    Kadayat TM; Park C; Jun KY; Magar TB; Bist G; Yoo HY; Kwon Y; Lee ES
    Bioorg Med Chem; 2015 Jan; 23(1):160-73. PubMed ID: 25481396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiproliferative evaluation of 6-arylindeno[1,2-c]quinoline derivatives.
    Tseng CH; Chen YL; Chung KY; Cheng CM; Wang CH; Tzeng CC
    Bioorg Med Chem; 2009 Nov; 17(21):7465-76. PubMed ID: 19796956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.